Skip to content
Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized

Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized

  • Post published:December 29, 2020
  • Post category:Press Release
Read more about the article Nova Mentis Expands Psychedelic Drug Pipeline

Nova Mentis Expands Psychedelic Drug Pipeline

  • Post published:December 29, 2020
  • Post category:Press Release
Read more about the article Cybin Announces First Quarter Financial Results of Clarmin Explorations Inc.

Cybin Announces First Quarter Financial Results of Clarmin Explorations Inc.

  • Post published:December 29, 2020
  • Post category:Press Release
Read more about the article BetterLife Pharma Strengthens Board of Directors

BetterLife Pharma Strengthens Board of Directors

  • Post published:December 29, 2020
  • Post category:Press Release
Read more about the article Mind Cure Announces Novel Supplement Product to Address Teen Wellness

Mind Cure Announces Novel Supplement Product to Address Teen Wellness

  • Post published:December 29, 2020
  • Post category:Press Release
Read more about the article Psyched Wellness Has Commenced Research on Muscimol for Various Ailments

Psyched Wellness Has Commenced Research on Muscimol for Various Ailments

  • Post published:December 28, 2020
  • Post category:Press Release
Read more about the article Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value

Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value

  • Post published:December 28, 2020
  • Post category:Press Release
Read more about the article First Psychedelic ETF Expected to Launch January 2021 (NEO:PSYK)

First Psychedelic ETF Expected to Launch January 2021 (NEO:PSYK)

  • Post published:December 28, 2020
  • Post category:Analysis/News
Read more about the article Entheon Biomedical Closes Private Placement

Entheon Biomedical Closes Private Placement

  • Post published:December 26, 2020
  • Post category:Press Release
Read more about the article Novamind Completes Reverse Takeover Transaction

Novamind Completes Reverse Takeover Transaction

  • Post published:December 24, 2020
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2026, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More